Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950123-20-007315
Filing Date
2020-07-29
Accepted
2020-07-29 21:54:27
Documents
1
Period of Report
2020-07-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4.html 4  
1 PRIMARY DOCUMENT doc4.xml 4 28993
  Complete submission text file 0000950123-20-007315.txt   30448
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address
Bolzon Bradley J PhD (Reporting) CIK: 0001354345 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 201058965

Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)